7,644 Astera Labs, Inc. $ALAB Shares Acquired by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 5.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 151,807 shares of the company’s stock after purchasing an additional 7,644 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Astera Labs were worth $54,039,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Diversify Advisory Services LLC boosted its stake in shares of Astera Labs by 1.1% during the third quarter. Diversify Advisory Services LLC now owns 7,599 shares of the company’s stock valued at $2,705,000 after purchasing an additional 81 shares in the last quarter. Net Worth Advisory Group purchased a new position in Astera Labs during the third quarter valued at approximately $1,032,000. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Astera Labs by 6.1% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 25,520 shares of the company’s stock valued at $9,084,000 after buying an additional 1,464 shares during the period. Teamwork Financial Advisors LLC raised its stake in Astera Labs by 32.5% in the third quarter. Teamwork Financial Advisors LLC now owns 5,246 shares of the company’s stock worth $1,867,000 after buying an additional 1,287 shares in the last quarter. Finally, Frank Rimerman Advisors LLC raised its stake in Astera Labs by 6.2% in the third quarter. Frank Rimerman Advisors LLC now owns 2,639 shares of the company’s stock worth $939,000 after buying an additional 154 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares in the company, valued at approximately $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of analyst reports. UBS Group restated a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Weiss Ratings upgraded Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Jefferies Financial Group lifted their price target on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Roth Capital reissued a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada upped their price objective on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $344.17.

Astera Labs Stock Down 11.1%

Shares of Astera Labs stock opened at $257.82 on Friday. The firm’s 50 day moving average price is $311.83 and its 200-day moving average price is $303.10. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The company has a market cap of $44.73 billion, a P/E ratio of 187.13 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the previous year, the business posted $0.44 EPS. Astera Labs’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 2.71 EPS for the current fiscal year.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.